Advanced Enzyme Technologies shareholders and shareholding pattern
NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap
Last close ₹248.35down ₹10.50 (4.06%)BSE ₹248.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹258.85.
52-week range of traded prices to 23 Oct 2026
₹246.85Low, 23 Oct 2026₹419.00High, 11 May 2026
- Next results date: the board meets on 31 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,760 Cr912th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 16.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 9 May 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 10.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,27,06958.5% delivered
Who owns Advanced Enzyme Technologies, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters43.56%
- Foreign institutions26.65%
- Indian institutions1.89%
- Individuals and others27.90%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 5 Jan | Mar 2017Filed 19 Apr | Jun 2017Filed 17 Jul | Sep 2017Filed 10 Oct | Dec 2017Filed 5 Jan | Mar 2018Filed 9 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 27 Oct | Dec 2018Filed 17 Jan | Mar 2019Filed 7 May | Jun 2019Filed 23 Jul | Sep 2019Filed 18 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 18 May | Jun 2020Filed 11 Aug | Sep 2020Filed 16 Oct | Dec 2020Filed 30 Jan | Mar 2021Filed 15 Apr | Jun 2021Filed 18 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 12 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 18 Jul | Sep 2023Filed 9 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 14 Oct | Dec 2024Filed 14 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 16 Jan | Mar 2026Filed 14 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.50% | 70.10% | 71.31% | 71.31% | 71.31% | 71.32% | 67.34% | 67.34% | 67.27% | 57.31% | 57.30% | 57.86% | 57.86% | 57.88% | 58.13% | 55.45% | 55.39% | 55.38% | 52.30% | 52.55% | 52.71% | 52.70% | 52.70% | 49.87% | 49.87% | 49.87% | 46.52% | 45.92% | 43.62% | 43.49% | 43.02% | 42.95% | 42.93% | 43.08% | 43.08% | 43.07% | 43.04% | 43.26% | 43.24% | 43.56% | |
| Indian promoters | 30.83% | 34.43% | 35.64% | 35.64% | 35.64% | 35.64% | 31.68% | 31.68% | 26.75% | 16.79% | 16.79% | 17.35% | 17.35% | 17.35% | 17.42% | 14.73% | 14.70% | 14.68% | 11.62% | 11.87% | 12.15% | 12.15% | 12.15% | 9.33% | 9.33% | 9.33% | 5.45% | 4.85% | 2.55% | 2.43% | 1.95% | 1.98% | 1.97% | 1.97% | 1.97% | 1.97% | 1.95% | 1.95% | 1.95% | 1.96% |
| Foreign promoters | 35.67% | 35.67% | 35.67% | 35.67% | 35.67% | 35.67% | 35.67% | 35.67% | 40.52% | 40.52% | 40.52% | 40.51% | 40.51% | 40.53% | 40.71% | 40.71% | 40.70% | 40.69% | 40.68% | 40.68% | 40.56% | 40.56% | 40.55% | 40.55% | 40.55% | 40.55% | 41.07% | 41.07% | 41.07% | 41.07% | 41.07% | 40.97% | 40.95% | 41.11% | 41.11% | 41.11% | 41.09% | 41.31% | 41.29% | 41.60% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 33.50% | 29.90% | 28.69% | 28.69% | 28.69% | 28.68% | 32.66% | 32.66% | 32.73% | 42.69% | 42.70% | 42.14% | 42.14% | 42.12% | 41.87% | 44.55% | 44.61% | 44.62% | 47.70% | 47.45% | 47.29% | 47.30% | 47.30% | 50.13% | 50.13% | 50.13% | 53.48% | 54.08% | 56.38% | 56.51% | 56.98% | 57.05% | 57.07% | 56.92% | 56.92% | 56.93% | 56.96% | 56.74% | 56.76% | 56.44% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 25.30% | 26.27% | 29.90% | 29.90% | 39.49% | 26.61% | 30.10% | 15.34% | 12.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 2,23,26,005 | 2,23,26,005 | 11,16,30,025what Shares in issue, Jun 2017, includes. Split on 25 May 2017: each share became 5. Earlier filings count the shares before it. | 11,16,30,025 | 11,16,30,025 | 11,16,30,025 | 11,16,48,825 | 11,16,48,825 | 11,16,48,825 | 11,16,48,975 | 11,16,68,075 | 11,16,76,475 | 11,16,76,475 | 11,16,78,475 | 11,16,78,475 | 11,16,78,475 | 11,17,23,925 | 11,17,28,425 | 11,17,78,300 | 11,17,78,300 | 11,17,91,475 | 11,18,00,675 | 11,18,06,575 | 11,18,22,075 | 11,18,22,075 | 11,18,24,075 | 11,18,24,075 | 11,18,24,075 | 11,18,24,075 | 11,18,24,075 | 11,18,24,075 | 11,18,24,075 | 11,18,80,650 | 11,18,81,150 | 11,18,81,150 | 11,18,81,150 | 11,19,26,800 | 11,19,26,800 | 11,19,76,150 | 11,11,51,122 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 1,70,06,400 | 1,69,82,680 | 8,49,13,400 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,44,805 | 2,23,44,805 | 2,23,46,055 | 2,23,44,955 | 2,23,45,255 | 27,650 | 27,650 | 29,500 | 10,400 | 2,000 | 47,450 | 49,950 | 99,825 | 99,825 | 67,550 | 72,250 | 28,275 | 43,775 | 30,600 | 23,400 | 17,500 | 2,000 | 2,000 | 0 | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Promoters' shares locked in | 1,48,46,860 | 1,48,46,860 | 7,42,34,300 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 2,23,26,005 | 0 | – | – | – | – | – | – | – | 0 | 1,800 | 1,800 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Advanced Enzyme Technologies promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Vasant Rathi, 26.87%. The filing names 8 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Vasant RathiNon-resident and foreign individuals | 26.87% | 2,98,71,702 |
| Vasant and Prabha Rathi Generation TrustForeign companies and others | 6.75% | 75,00,000 |
| Rasika Vasant RathiNon-resident and foreign individuals | 2.40% | 26,65,825 |
| Reshma Namita RathiNon-resident and foreign individuals | 2.38% | 26,46,858 |
| Rachana Vasant RathiNon-resident and foreign individuals | 2.38% | 26,41,500 |
| Kishor Laxminarayan Rathi HUFIndividuals and Hindu undivided families | 0.99% | 11,00,000 |
| Prabhavati Vasant RathiNon-resident and foreign individuals | 0.82% | 9,13,000 |
| Madhusudan KabraIndividuals and Hindu undivided families | 0.55% | 6,15,600 |
| Kishor Laxminarayan RathiIndividuals and Hindu undivided families | 0.37% | 4,06,000 |
| Jayesh Madhusudan SoniIndividuals and Hindu undivided families | 0.01% | 10,000 |
| Snehal Shamsunder SoniIndividuals and Hindu undivided families | 0.01% | 15,000 |
| Pratik Prakash KokaneIndividuals and Hindu undivided families | 0.01% | 10,000 |
No promoter shares are reported as pledged.
Largest public holders of Advanced Enzyme Technologies, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Advanced Enzyme Technologies
| Holder | Dec 2016Filed 5 Jan | Mar 2017Filed 19 Apr | Jun 2017Filed 17 Jul | Sep 2017Filed 10 Oct | Dec 2017Filed 5 Jan | Mar 2018Filed 9 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 27 Oct | Dec 2018Filed 17 Jan | Mar 2019Filed 7 May | Jun 2019Filed 23 Jul | Sep 2019Filed 18 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 18 May | Jun 2020Filed 11 Aug | Sep 2020Filed 16 Oct | Dec 2020Filed 30 Jan | Mar 2021Filed 15 Apr | Jun 2021Filed 18 Jul | Sep 2021Filed 18 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 12 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 18 Jul | Sep 2023Filed 9 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 14 Oct | Dec 2024Filed 14 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 16 Oct | Dec 2025Filed 16 Jan | Mar 2026Filed 14 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orbimed Asia III Mauritius FVCI LimitedForeign direct investment | – | – | – | – | – | – | – | – | – | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 12.08% | 12.08% | 12.07% | 12.07% | 12.07% | 12.07% | 12.07% | 12.07% | 12.06% | 12.15% |
| Nalanda India Equity Fund LimitedForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.75% | 4.74% | 4.74% | 4.74% | 4.74% | 4.74% | 6.11% | 6.23% | 8.91% | 8.91% | 8.91% | 8.91% | 8.91% | 8.91% | 8.91% | 8.46% | 8.46% | 8.46% | 8.46% | 8.46% | 8.46% | 8.46% | 8.46% | 8.45% | 8.38% |
| Polunin Emerging Markets Small Cap Fund, LLCForeign portfolio investors, category II | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.37% | 1.38% | 1.32% | 2.46% | 2.48% |
| Marval Guru FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.00% | 1.00% | 1.00% | 1.00% | 1.41% | 1.79% | 1.79% | 1.79% | 1.80% |
| Pradip Bhailal ShahNon-resident Indians | 1.80% | 1.80% | 1.80% | 1.80% | 1.80% | – | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.82% | 1.82% | 1.91% | 1.91% | 1.91% | 1.91% | 1.89% | 1.87% | 1.87% | 1.87% | 1.86% | 1.85% | 1.85% | 1.85% | 1.83% | 1.81% | 1.81% | 1.80% | 1.71% | 1.70% | 1.70% | 1.70% | 1.70% | 1.68% | 1.66% | 1.66% | 1.67% |
| Mukund Madhusudan KabraDirectors and their relatives | – | 1.51% | 1.51% | 1.51% | 1.51% | – | 1.51% | 1.51% | – | 1.51% | 1.51% | 1.51% | 1.51% | 1.62% | 1.62% | 1.62% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.64% |
| Clarus Capital IAlternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.28% | 1.51% | 1.82% | 1.99% | 2.15% | 2.27% | 2.43% | 2.65% | 2.75% | 2.28% | – |
| Orbimed Asia III Mauritius LimitedForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | 9.90% | 9.90% | 9.90% | 9.90% | 9.90% | 9.90% | 9.90% | 9.89% | 9.89% | 9.89% | 9.89% | 9.89% | 9.89% | 9.89% | 9.88% | 9.88% | 9.88% | 9.88% | 9.88% | 9.88% | 9.88% | – | – | – | – | – | – | – | – | – | – |
| Sri Sri Ravi Shankar TrustOther non-institutions | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | 1.05% | – | – | – | – | – | – | – | – | – | – | – |
| Mukund KabraResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Pradip B ShahOther non-institutions | – | – | – | – | – | 1.80% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Mukund M KabraResident individuals, over ₹2 lakh at face value | 1.51% | – | – | – | – | 1.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Arvind VarchaswiResident individuals, over ₹2 lakh at face value | – | – | – | – | 1.01% | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| The Nomura Trust and Banking Co., Ltd As The Trustee of Nomura India Stock Mother FundInstitutions Foreign Portfolio Investor | – | 1.02% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.